300676 华大基因
2025/06 - 中期
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(413,838)95,723408,768130,8832,476,132
投资活动产生之现金流量净额(532,642)(314,416)(1,750,741)(580,074)(2,292,050)
筹资活动产生之现金流量净额387,173(683,152)(266,882)(1,194,537)1,037,307
汇率变动对现金及现金等价物的影响11,95145,12132,822279,379(139,909)
现金及现金等价物净增加/(减少)(547,355)(856,724)(1,576,033)(1,364,349)1,081,480
期初现金及现金等价物余额2,698,4173,555,1415,131,1746,495,5235,410,064
期末现金及现金等价物余额2,151,0622,698,4173,555,1415,131,1746,491,544